Rubin Steven D
- SEC CIK
- 0001381874
In the past year, 2 open-market purchase filings worth $19.4K and no sales.
Current role at each company
- ENTX Entera Bio Ltd.Directoras of Aug 7, 2026
- OPK Opko Health, Inc.Executive VP-Administrationas of Jul 28, 2026
- NAGE Niagen Bioscience, Inc.Directoras of Jun 26, 2026
- ELOX Eloxx Pharmaceuticals, Inc.Directoras of Jun 10, 2026
- RDVT Red Violet, Inc.Directoras of Jun 5, 2026
Show 1 more company
- COCP Cocrystal Pharma, Inc.Directoras of Jan 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $19.4K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$19.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rubin Steven D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ENTX Entera Bio Ltd.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 (view filing) | Feb 12 | 5 days | Rubin Steven DDirector | PPurchaseOrdinary Shares, par value NIS 0.0000769 per share | +5.00K | $1.49 | +$7.45K | +50.0%15.0K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Rubin Steven DDirector | PPurchaseOrdinary Shares, par value NIS 0.0000769 per share | +10.0K | $1.20 | +$12.0K | New position10.0K after |
RDVT Red Violet, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 (view filing) | Mar 19 | 2 days | Rubin Steven DDirector | SSale | −10.0K | $38.93 | −$389.3K | −6.6%141.1K after |
OPK Opko Health, Inc.
Executive VP-Administration2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 (view filing) | Jan 5 | Same day | Rubin Steven DExecutive VP-Administration | PPurchase | +10.0K | $0.87 | +$8.70K | +0.2%6.19M after | |
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Rubin Steven DExecutive VP-Administration | PPurchase | +10.0K | $1.30 | +$13.0K | +0.2%6.18M after |
NAGE Niagen Bioscience, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing) | May 25 | 5 days | Rubin Steven DDirector | PPurchase | +7.00K | $1.46 | +$10.2K | New position7.00K after |